Human glial progenitors transplanted into a chimeric mouse brain replace sick or older human glia, a finding that could one day lead to new treatments for neurological disease.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Valori, C. F., Possenti, A., Brambilla, L. & Rossi, D. Cells 10, 2019 (2021).
Vieira, R. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01798-5 (2023).
Allen, N. J. & Lyons, D. A. Science 362, 181–185 (2018).
Osorio, M. J. et al. Glia 71, 524–540 (2023).
Han, X. et al. Cell Stem Cell 12, 342–353 (2013).
Benraiss, A. et al. Nat. Commun. 7, 11758 (2016).
Das, M. M. & Svendsen, C. N. Aging (Albany NY) 36, 1130–1139 (2015).
Das, M. M. et al. Exp. Neurol. 280, 41–49 (2016).
Baloh, R. H. et al. Nat. Med. 28, 1813–1822 (2022).
Vera, E., Bosco, N. & Studer, L. Cell Rep. 17, 1184–1192 (2016).
Sorrells, S. F. et al. Nature 555, 377–381 (2018).
Boldrini, M. et al. Cell Stem Cell 22, 589–599.e5 (2018).
The authors declare no competing interests.
About this article
Cite this article
Moser, V.A., Svendsen, C.N. Survival of the fittest glia. Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-01944-z